$4.97 0.03 (+0.61%)
11/6/2009 4:00 PM

Pain Therapeutics, Inc. (PTIE)

CAPS Rating: 5 out of 5

A biopharmaceutical company that develops novel drugs for pain management and oncology.

Current Price $4.97 Mkt Cap $209.88M
Open $4.90 P/E Ratio 19.21
Prev. Close $4.94 Div. (Yield) N/A (N/A)
Daily Range $4.80 - $4.99 Volume 72,208
52-Wk Range $3.20 - $9.37 Avg. Daily Vol. 262,000

PTIE News and Commentary

Caps

How do you think PTIE will perform vs the S&P 500?

Add Stock to Watchlist

All Members

205 Outperform
15 Underperform
 

All-Star Members

68 Outperform
5 Underperform
 

Wall Street

2 Outperform
2 Underperform
 

Top PTIE Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

JiminyBillyBob (55.77)
Submitted February 25, 2008

Tons of cash and no long term debt. While this company's prospects depend on future FDA approvals, it has enough of a cushion courtesy of King Pharmaceuticals in case things do not go as planned. Even risk-adverse investors should take a look at this… More

0 Comments | Reply | Report this Post

NetscribeBiotech (36.01)
Submitted May 30, 2007

The world pain management market is growing at a brisk pace and any company that is ready with a compound to tap this growing market has all reasons to cheer. Having said that Pain Therapeutics, which develops drugs catering to this segment as well… More

0 Comments | Reply | Report this Post
PTIE VS S&P 500 (SPY)

Fools bullish on PTIE are also bullish on:

Fools bearish on PTIE are also bearish on:

Recent Community Commentary

Read the most recent pitches from members about PTIE.

Recs

0
Member Avatar d0319a (40.26) Submitted: 9/22/2009 8:26:41 AM : Outperform Start Price: $5.36 PTIE Score: -7.36

pipeline and cash

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar FinanceGuy58 (30.82) Submitted: 9/17/2009 9:01:03 PM : Outperform Start Price: $5.32 PTIE Score: -6.72

A virtual pharma development company with several shots on goal. Remoxy already partnered with King Pharma. Abuse resistant forms of oxycontin should be a big hit. Great royalty rates. Another pic, Durect provides the drug delivery system for one of their pipeline products. PTIE holds tons of cash too - not going away. Very lean company, they outsource almost everything.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar ZiggyLuckyShadow (71.86) Submitted: 9/8/2009 3:43:36 PM : Outperform Start Price: $5.29 PTIE Score: -10.77

There were 30 items in your list. Here they are in random order:

ITWO - 1 (3 Star)
SOLR - Already on list
AMED - 2 (2 Star)
NTRI - 3 (3 Star)
CBI - 4 (5 Star)
CYTK - 5 (2 Star)
FWLT - Already on list
USMO - Already on list
PTIE - 6 (5 Star)
ELNK
GTLS
JCOM
FIX
QCOR
KHD
PPD
UNTD
LO
VCLK
GIGM
EME
FRX
ENDP
DIVX
EXBD
TRA
VM
DLX
INT
PRIM
Timestamp: 2009-09-08 19:37:25 UTC

Report this Post 0 Comments | Reply | Permalink
View All 33 Pitches »

Leaderboard

Find the members with the highest scoring picks in PTIE.

Score Leader

foolrrrrrrrrrr

foolrrrrrrrrrr (28.52) Score: +74.78

The Score Leader is the member with the highest score across all their picks in PTIE.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
foolrrrrrrrrrr 28.52 11/13/2008 Underperform 1Y $8.99 -44.72% +30.06% +74.78
Dennyf10 < 20 10/16/2008 6/22/2009 Underperform 1Y $8.54 -41.80% +20.07% +61.87
marcet 69.23 3/2/2009 Underperform 3W $4.50 +10.44% +50.34% +39.90
kozmo66 < 20 9/22/2008 Underperform 3M $9.25 -46.27% -11.78% +34.49
deemonfather42 85.33 7/6/2009 Underperform 3W $5.36 -7.28% +20.37% +27.64
calonp 85.99 10/19/2006 Underperform 3M $8.51 -41.60% -16.60% +25.00
chhautbrion 97.64 8/27/2007 Underperform 5Y $9.64 -48.44% -23.73% +24.72
Whereismymony 65.94 12/8/2006 Underperform 3M $8.67 -42.68% -19.41% +23.26
therapy1992 47.05 12/11/2006 Underperform 1Y $8.56 -41.94% -19.60% +22.34
hackerbobZ 30.89 3/23/2009 Underperform 5Y $4.22 +17.77% +37.48% +19.70
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackJGreenblatt 48.54 4/20/2009 Outperform 1Y $4.30 +15.58% +26.54% -10.96 1 Comment
TrackZacks 69.52 11/14/2008 Underperform 3M $8.57 -52.51% -0.94% +51.57 4/11/2009 @ $4.07 1 Comment
TrackMerriman < 20 6/5/2008 Outperform NS $8.09 +3.96% +1.46% +2.50 6/5/2008 @ $8.41
TrackPZK < 20 3/28/2008 Outperform NS $7.97 -37.64% -16.32% -21.32
TrackCreditSuiss 91.16 2/28/2008 Underperform NS $9.02 -50.78% -36.98% +13.80 4/17/2009 @ $4.44
TrackBroadpoint.AmTech 73.02 12/21/2007 Underperform NS $10.85 -15.21% -9.64% +5.57 2/8/2008 @ $9.20
TrackJimCramer < 20 2/27/2007 Underperform 3W $7.86 -36.77% -18.49% +18.28
TrackNeedham < 20 11/9/2006 Outperform NS $8.10 +6.30% +8.34% -2.04 5/3/2007 @ $8.61
TrackUBS 86.41 10/26/2006 Underperform NS $8.66 -42.61% -18.02% +24.59
TrackJimCramer < 20 3/2/2006 Outperform 3W $11.00 -28.55% +8.40% -36.95 2/28/2007 @ $7.86

Featured Broker Partners